These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18805611)

  • 41. Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome.
    Bienaime F; Dragon-Durey MA; Regnier CH; Nilsson SC; Kwan WH; Blouin J; Jablonski M; Renault N; Rameix-Welti MA; Loirat C; Sautés-Fridman C; Villoutreix BO; Blom AM; Fremeaux-Bacchi V
    Kidney Int; 2010 Feb; 77(4):339-49. PubMed ID: 20016463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inherited deficiency of membrane cofactor protein expression and varying manifestations of recurrent atypical hemolytic uremic syndrome in a sibling pair.
    Couzi L; Contin-Bordes C; Marliot F; Sarrat A; Grimal P; Moreau JF; Merville P; Fremeaux-Bacchi V
    Am J Kidney Dis; 2008 Aug; 52(2):e5-9. PubMed ID: 18514989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of a factor H mutation with hemolytic uremic syndrome following a diarrheal illness.
    Edey MM; Mead PA; Saunders RE; Strain L; Perkins SJ; Goodship TH; Kanagasundaram NS
    Am J Kidney Dis; 2008 Mar; 51(3):487-90. PubMed ID: 18295065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.
    Caprioli J; Noris M; Brioschi S; Pianetti G; Castelletti F; Bettinaglio P; Mele C; Bresin E; Cassis L; Gamba S; Porrati F; Bucchioni S; Monteferrante G; Fang CJ; Liszewski MK; Kavanagh D; Atkinson JP; Remuzzi G;
    Blood; 2006 Aug; 108(4):1267-79. PubMed ID: 16621965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atypical hemolytic uremic syndrome: telling the difference between H and Y.
    Goicoechea de Jorge E; Pickering MC
    Kidney Int; 2010 Oct; 78(8):721-3. PubMed ID: 20877372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome.
    Martinez-Barricarte R; Pianetti G; Gautard R; Misselwitz J; Strain L; Fremeaux-Bacchi V; Skerka C; Zipfel PF; Goodship T; Noris M; Remuzzi G; de Cordoba SR;
    J Am Soc Nephrol; 2008 Mar; 19(3):639-46. PubMed ID: 18235085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.
    Le Quintrec M; Lionet A; Kamar N; Karras A; Barbier S; Buchler M; Fakhouri F; Provost F; Fridman WH; Thervet E; Legendre C; Zuber J; Frémeaux-Bacchi V
    Am J Transplant; 2008 Aug; 8(8):1694-701. PubMed ID: 18557729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel use of intravenous immunoglobulin G in complement factor H missense mutation: a case report.
    Neidich AB; Neidich EM; Lee A; Nicoletta J; Rohrer RJ; Milner LS; Cooper JT
    Prog Transplant; 2013 Sep; 23(3):213-6. PubMed ID: 23996939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-transplant recurrence of atypical hemolytic uremic syndrome in a patient with thrombomodulin mutation.
    Sinibaldi S; Guzzo I; Piras R; Bresin E; Emma F; Dello Strologo L
    Pediatr Transplant; 2013 Dec; 17(8):E177-81. PubMed ID: 24118826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: successful treatment with intensive plasma exchanges and ganciclovir.
    Olie KH; Goodship TH; Verlaak R; Florquin S; Groothoff JW; Strain L; Weening JJ; Davin JC
    Am J Kidney Dis; 2005 Jan; 45(1):e12-5. PubMed ID: 15696434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of renal transplant in patients with anti-complement factor H antibody-associated hemolytic uremic syndrome.
    Khandelwal P; Sinha A; Hari P; Bansal VK; Dinda AK; Bagga A
    Pediatr Transplant; 2014 Aug; 18(5):E134-9. PubMed ID: 24814615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful isolated liver transplantation in a child with atypical hemolytic uremic syndrome and a mutation in complement factor H.
    Haller W; Milford DV; Goodship TH; Sharif K; Mirza DF; McKiernan PJ
    Am J Transplant; 2010 Sep; 10(9):2142-7. PubMed ID: 20738267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrence of hemolytic uremic syndrome after renal transplantation.
    Seitz B; Albano L; Vocila F; Mzoughi S; Aoudia R; Guitard J; Ribes D; Vachet-Copponat H; Mourad G; Bienaimé F; Dahan P; Frémeaux-Bacchi V; Cassuto E
    Transplant Proc; 2007 Oct; 39(8):2583-5. PubMed ID: 17954182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Eculizumab for atypical hemolytic-uremic syndrome.
    Nürnberger J; Philipp T; Witzke O; Opazo Saez A; Vester U; Baba HA; Kribben A; Zimmerhackl LB; Janecke AR; Nagel M; Kirschfink M
    N Engl J Med; 2009 Jan; 360(5):542-4. PubMed ID: 19179328
    [No Abstract]   [Full Text] [Related]  

  • 55. Complement dysfunction in hemolytic uremic syndrome.
    Zipfel PF; Skerka C
    Curr Opin Rheumatol; 2006 Sep; 18(5):548-55. PubMed ID: 16896298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atypical haemolytic uraemic syndrome.
    Kavanagh D; Goodship TH; Richards A
    Br Med Bull; 2006; 77-78():5-22. PubMed ID: 16968692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.
    Kavanagh D; Richards A; Noris M; Hauhart R; Liszewski MK; Karpman D; Goodship JA; Fremeaux-Bacchi V; Remuzzi G; Goodship TH; Atkinson JP
    Mol Immunol; 2008 Jan; 45(1):95-105. PubMed ID: 17597211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
    Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP
    J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
    Kavanagh D; Goodship TH
    Hematology Am Soc Hematol Educ Program; 2011; 2011():15-20. PubMed ID: 22160007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report.
    Châtelet V; Lobbedez T; Frémeaux-Bacchi V; Ficheux M; Ryckelynck JP; Hurault de Ligny B
    Transplant Proc; 2010 Dec; 42(10):4353-5. PubMed ID: 21168697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.